"This is another significant step in our strategy to expand Teva's presence in growing markets, and excluding Japan, this is our first alliance in East Asia," said Itzhak Krinsky, Teva's Asia Pacific business development chief and chairman of Teva South Korea, adding that the two companies "plan to
Date: Dec 17, 2012
Category: Business
Source: Google
Teva, South Korea's Handok Pharmaceuticals form joint venture
his is another significant step in our strategy to expand Tevas presence in growing markets and excluding Japan, this is our first alliance in East Asia, Prof. Itzhak Krinsky, who is leads Teva's Japanese and Korean divisions and head other Asia Pacific business development, said in a statement. By
Date: Dec 17, 2012
Category: Business
Source: Google
Teva sells animal drug unit to Bayer for up to $145 million
We are pleased with the sale of our animal healthcare business to Bayer HealthCare, a leader in animal healthcare, Itzhak Krinsky, Teva executive vice president and head of business development, said in a statement. Todays transaction represents a successful outcome for both parties and is a par
Date: Sep 14, 2012
Category: Business
Source: Google
Bayer HealthCare to Buy Teva Animal Health Business for up to $145M
As part of our overall strategy to refine our global footprint, we will continue to leverage our product portfolio and R&D efforts while selling or outlicensing assets that no longer fit within the scope of our business, notes Itzhak Krinsky, group executive vp and head of business developmen